As people who understand the stock market, and understand how weak LDX currently is the 10% drop comes as no surprise.
It's all very well having a reimbursement code, but no use at all if GP's aren't actually buying the product in the first place.
I have no doubt, barring unexpected announcements, that this will be back to 3c within days.
We need the CLIA waiver test to start, but more importantly the product sales figures in January.
This all changes with the Hologic 'royalties' contract, and a good set of product sales figures.
Until then, it's a chance to average down if you still believe in the underlying fundamentals.
12 months of funding left to get LDX on the right path or the lights go out
Add to My Watchlist
What is My Watchlist?
